News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medarex Partners Up Again


10/19/2005 5:12:07 PM

Medarex and Bristol-Myers Squibb announced a deal today to develop and market MDX-010, a melanoma treatment developed by Medarex. As part of the collaboration, Britsol-Myers will purchase a $25 million stake in Medarex, at a premium to the market and make a $25 million cash payment. The partnership also includes MDX-1379, a vaccine to be developed for possible combined use with MDX-010 in melanoma.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES